EYA1 Human shRNA Plasmid Kit (Locus ID 2138)
CAT#: TR304716
EYA1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | EYA1 Human shRNA Plasmid Kit (Locus ID 2138) |
Locus ID | 2138 |
UniProt ID | Q99502 |
Synonyms | BOP; BOR; BOS1; OFC1 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | EYA1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 2138). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_000503, NM_001288574, NM_001288575, NM_172058, NM_172059, NM_172060, NM_172059.1, NM_172059.2, NM_172059.3, NM_172060.1, NM_172060.2, NM_172060.3, NM_000503.1, NM_000503.2, NM_000503.3, NM_000503.4, NM_000503.5, NM_172058.1, NM_172058.2, NM_172058.3, NM_001288575.1, NM_001288574.1, BC121799, BC035138, BC048982, BC121798, NM_001370334, NM_001370335, NM_001370333, NM_001370336, NM_001288574.2, NM_000503.6, NM_001288575.2, NM_172058.4 |
Summary | This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may play a role in the developing kidney, branchial arches, eye, and ear. Mutations of this gene have been associated with branchiootorenal dysplasia syndrome, branchiootic syndrome, and sporadic cases of congenital cataracts and ocular anterior segment anomalies. A similar protein in mice can act as a transcriptional activator. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2013] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
EYA1's conformation-specificity in dephosphorylating phosphothreonine in Myc and its activity on Myc stabilization in breast cancer
,Li, J;Rodriguez, Y;Cheng, C;Zeng, L;Wong, EY;Xu, CY;Zhou, MM;Xu, PX;,
Mol. Cell. Biol.
,PubMed ID 27795300
[EYA1]
|
Regulation of the innate immune response by threonine-phosphatase of Eyes absent
,Okabe Y, Sano T, Nagata S.,
Nature. 2009 Jul 23;460(7254):520-4.
[EYA1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...